Morabito Christopher 4
4 · Astria Therapeutics, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Morabito Christopher
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-01+100,000→ 100,000 totalExercise: $3.87Exp: 2032-07-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option was granted on August 1, 2022, pursuant to the Astria Therapeutics, Inc. 2022 Inducement Stock Incentive Plan and the terms and conditions of an award agreement covering the option grant. This option is subject to vesting over a four year period, with 25% of shares vesting on the first anniversary of July 14, 2022, the reporting person's employment start date, and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.